Novo Nordisk asks FDA to ban cheap copies of Wegovy, Ozempic, CNBC reports
Novo Nordisk (NVO) has asked the FDA to ban cheap copies of its weight loss drugs Wegovy and Ozempic, arguing they pose safety risks, ...
Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program
Bayer obtains global license to develop and commercialize disease-modifying treatment specifically for dilated cardiomyopathy (DCM) patients ...
pharmaphorum13h
Hyntelo: AI solutions for improved customer engagement
Hyntelo, one of the first Veeva AI Partners, empowers Life Sciences businesses to harness data and adopt AI solutions. Our ...
Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies
Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO) on Tuesday asked the U.S. Food and Drug Administration to ban compounding ...